Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.1579
0.00 (0.00%)
Aug 28, 2025, 10:47 AM EDT
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $766.58 thousand as of August 29, 2025. Its market cap has decreased by -59.49% in one year.
Market Cap
766.58K
Enterprise Value
2.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 766.58K, a decrease of -99.14%. That is a compound annual growth rate of -38.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 766.58K | -58.45% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | 34.35M | 23.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2015 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 840.66M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.71M |
| Elite Pharmaceuticals | 586.30M |
| CytoDyn | 397.64M |
| American Oncology Network | 369.59M |
| Northwest Biotherapeutics | 357.21M |